A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
2013 ◽
Vol 11
(3)
◽
pp. 181-192
◽
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 91
(3)
◽
pp. 684-697.e15
◽